Australian biotech market today 26.03.09
Thursday, 26 March, 2009
The pharma and biotech index is up 2.35 per cent at 3.00pm on a generally positive day for the share market.
Cochlear (ASX:COH) is up 63c and CSL (ASX:CSL) is up 79c, while Resmed (ASX:RMD) has had smaller gains.
Progen (ASX:PGL) is up a bit on news of its share buyback. Alchemia (ASX:ACL) is up a touch to 29c and Genera Biosystems (ASX:GBI) is up 5c, both on the back of new share options.
Peplin (ASX:PLI) is up 4c on small trades while Sonic Healthcare (ASX:SHL) is up a cent to $11.32.
ChemGenex (ASX:CXS) is down slightly, as is Novogen (ASX:NRT).
Noxopharm says paper reveals science behind its immune system platform
Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...
argenx and Monash University partner against autoimmune diseases
To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...
